CELLACT PHARMA GMBH has a total of 19 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FARON PHARMACEUTICALS OY, HARRIS ADRIAN L and ARCH CANCER THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Hong Kong | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Utku Nalan | 19 |
#2 | Gullans Steven R | 4 |
#3 | Schlawinsky Mirko | 1 |
Publication | Filing date | Title |
---|---|---|
EP3211091A1 | Method for the diagnosis of etoposide prodrug treatable cancer | |
WO2014140072A1 | Etoposide and prodrugs thereof for use in targeting cancer stem cells | |
EP2558477A1 | Analogues of etoposide for the treatment of metastatic tumours |